Full Text View
Tabular View
No Study Results Posted
Related Studies
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
This study has been completed.
Study NCT00227110   Information provided by The University of Texas Health Science Center at San Antonio
First Received: September 23, 2005   Last Updated: October 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nonalcoholic Steatohepatitis
Additional conditions recognized in this trial
Fatty Liver
More general conditions related to this trial
Digestive System Diseases
Liver Diseases
Interventions listed in this trial
Pioglitazone
Placebo
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
The University of Texas Health Science Center at San Antonio
National Institutes of Health (NIH)
Takeda Pharmaceuticals North America, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services